Shravan Dave

机构：University of California San Diego · ORCID：0000-0002-2875-4926

发表论文 25 篇 · 总被引 729 次 · h-index 11

代表论文

• Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease (2020 · Gastroenterology · 被引 170)
• Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis (2024 · Journal of Hepatology · 被引 101)
• Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH (2021 · Alimentary Pharmacology & Therapeutics · 被引 91)
• Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta‐Analysis (2020 · Hepatology · 被引 83)
• Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease (2022 · Journal of Clinical Investigation · 被引 68)
• Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis (2022 · Clinical Gastroenterology and Hepatology · 被引 67)